Add to ORKGInnate resistance to several transplantable tumors loaded with α-Galactosyl ceramidehttps://digitalcommons.rockefeller.edu/nkt-cells/1009/thumbnail.jp
The study of the cellular and molecular basis of acquired drug resistance in cancer has been dominat...
We have obtained a novel multidrug resistant cell line, derived from HT29 G(+) human colon carcinoma...
BACKGROUND: Acquired resistance to cisplatin treatment is a caveat when treating patients with non-s...
B16 melanoma loaded with α-Galactosyl ceramide, elicit T cell-independent innate resistance to metas...
Innate responses to mouse transplantable tumorshttps://digitalcommons.rockefeller.edu/nkt-cells/1006...
Slide 5-41: α-Galactosyl ceramide can act as an adjuvant by recruiting NKT cells to mature DCs J. Ex...
Drug resistance, which is often of a multiple type, can be defined as the ability of cancer cells to...
Slide 5-14: B16 melanoma cells, coated with α-Galactosyl ceramide and injected intravenously, allow ...
Slide 5-16: A single dose of J558/GalCer tumor cells induces long-lived resistance to tumor challeng...
It was recently proposed that UDP-galactose:ceramide galactosyltransferase (UGT8), enzyme responsibl...
Slide 5-28: Effective adaptive immunity to tumors in mice that have rejected tumors via NKT and NK c...
Enhanced ceramide glycosylation catalyzed by glucosylceramide synthase (GCS) limits therapeutic effi...
Multidrug resistance is a dramatic complication that can impede cancer treatment. Some cancer cells ...
Slide 5-14: Resistance to B16 melanoma, following injection of CD1d-B16/GalCer i.v., requires CD4+ a...
PTX (Paclitaxel) is an antimitotic agent used in the treatment of a no. of major solid tumors, parti...
The study of the cellular and molecular basis of acquired drug resistance in cancer has been dominat...
We have obtained a novel multidrug resistant cell line, derived from HT29 G(+) human colon carcinoma...
BACKGROUND: Acquired resistance to cisplatin treatment is a caveat when treating patients with non-s...
B16 melanoma loaded with α-Galactosyl ceramide, elicit T cell-independent innate resistance to metas...
Innate responses to mouse transplantable tumorshttps://digitalcommons.rockefeller.edu/nkt-cells/1006...
Slide 5-41: α-Galactosyl ceramide can act as an adjuvant by recruiting NKT cells to mature DCs J. Ex...
Drug resistance, which is often of a multiple type, can be defined as the ability of cancer cells to...
Slide 5-14: B16 melanoma cells, coated with α-Galactosyl ceramide and injected intravenously, allow ...
Slide 5-16: A single dose of J558/GalCer tumor cells induces long-lived resistance to tumor challeng...
It was recently proposed that UDP-galactose:ceramide galactosyltransferase (UGT8), enzyme responsibl...
Slide 5-28: Effective adaptive immunity to tumors in mice that have rejected tumors via NKT and NK c...
Enhanced ceramide glycosylation catalyzed by glucosylceramide synthase (GCS) limits therapeutic effi...
Multidrug resistance is a dramatic complication that can impede cancer treatment. Some cancer cells ...
Slide 5-14: Resistance to B16 melanoma, following injection of CD1d-B16/GalCer i.v., requires CD4+ a...
PTX (Paclitaxel) is an antimitotic agent used in the treatment of a no. of major solid tumors, parti...
The study of the cellular and molecular basis of acquired drug resistance in cancer has been dominat...
We have obtained a novel multidrug resistant cell line, derived from HT29 G(+) human colon carcinoma...
BACKGROUND: Acquired resistance to cisplatin treatment is a caveat when treating patients with non-s...